IVME Historical Financial Ratios
| IVME Stock | USD 0.0001 0.00 0.000003% |
In Veritas is lately reporting on over 101 different financial statement accounts. To analyze all of these accounts together requires a lot of time and effort. However, using these accounts to derive some meaningful and actionable indicators such as Stock Based Compensation To Revenue of 0.0 or Capex To Depreciation of 7.84 will help investors to properly organize and evaluate In Veritas Medical financial condition quickly.
IVME |
About IVME Financial Ratios Analysis
In Veritas MedicalFinancial ratios are relationships based on a company's financial information. They can serve as useful tools to evaluate In Veritas investment potential. Financial ratio analysis can also be defined as the process of presenting financial ratios, which are mathematical indicators calculated by comparing key financial information appearing on IVME financial statements. Financial ratios are useful tools that help investors analyze and compare relationships between different pieces of financial information across In Veritas history.
In Veritas Financial Ratios Chart
Add Fundamental
Ptb Ratio
Price-to-Book ratio, a financial valuation metric used to compare a company's current market price to its book value. It provides insight into the value that market participants place on the company's equity relative to its net asset value.Stock Based Compensation To Revenue
A metric that compares the total value of stock-based compensation granted by a company to its total revenue, indicating how much of the revenue is used to compensate employees with stock options or awards.Most ratios from In Veritas' fundamentals are interrelated and interconnected. However, analyzing fundamentals ratios one by one will only give a small insight into In Veritas Medical current financial condition. On the other hand, looking into the entire matrix of fundamentals ratios, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in In Veritas Medical. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in population. At present, In Veritas' Capex To Depreciation is projected to increase slightly based on the last few years of reporting. The current year's ROIC is expected to grow to 0.37, whereas PTB Ratio is forecasted to decline to (0.04).
| 2010 | 2011 | 2023 | 2024 (projected) | Income Quality | 1.96 | 0.2 | 0.23 | 0.22 | Days Payables Outstanding | 200.2K | 56.8K | 65.3K | 62.0K |
In Veritas fundamentals Correlations
Click cells to compare fundamentals
In Veritas Account Relationship Matchups
High Positive Relationship
High Negative Relationship
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.When determining whether In Veritas Medical is a strong investment it is important to analyze In Veritas' competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact In Veritas' future performance. For an informed investment choice regarding IVME Stock, refer to the following important reports:Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in In Veritas Medical. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in population. You can also try the Financial Widgets module to easily integrated Macroaxis content with over 30 different plug-and-play financial widgets.
Is Asset Management & Custody Banks space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of In Veritas. If investors know IVME will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about In Veritas listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (0.01) | Return On Assets (6.48) |
The market value of In Veritas Medical is measured differently than its book value, which is the value of IVME that is recorded on the company's balance sheet. Investors also form their own opinion of In Veritas' value that differs from its market value or its book value, called intrinsic value, which is In Veritas' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because In Veritas' market value can be influenced by many factors that don't directly affect In Veritas' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between In Veritas' value and its price as these two are different measures arrived at by different means. Investors typically determine if In Veritas is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, In Veritas' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.